NM Genomix
NM Genomix is a small, privately held, for-profit healthcare organization headquartered in Sofia, Bulgaria, operating with 1–10 employees to provide medical services and products. Its specific clinical focus, customer base, and product portfolio are not disclosed in available sources.
- Company typePrivate
- Founded-
- HeadquartersSofia, Bulgaria
- Headcount1–10
- GTM typeB2B
- OfferingServices
What NM Genomix does
NM Genomix is a privately held, for-profit healthcare organization headquartered in Sofia, Bulgaria. Per its firmographic record, the company provides medical services and products. It operates at a micro scale, with an employee count in the 1–10 range, and is registered as a private entity with no disclosed public ticker, parent company, or subsidiaries. The website domain nmgenomix.com is registered to the company, but the scraped source material returned only a bot-verification/loader page with no substantive corporate content accessible.
No detailed product or service catalog is available: products_and_services, technology stack (core_technology, proprietary_features), pricing models, customer segments, marketing channels, distribution channels, and value-proposition fields are all empty or unpopulated in the source data. No certifications, regulatory actions, partnerships, patents, awards, or app/API offerings are documented. The company has no disclosed management team, no founding date, no legal entity name beyond the trade name, and no funding history on record.
Given the extreme data sparsity, NM Genomix cannot be characterized beyond the high-level description of a small Bulgarian healthcare provider of unspecified clinical focus. No revenue figures, headcount trends, geographic footprint beyond the Sofia headquarters, or competitive positioning signals are available in the scraped sources. Any deeper diligence on its clinical specialty, regulatory posture, customer base, or financial profile would require primary research or direct engagement with company management.
NM Genomix firmographics
Firmographics- Name
- NM Genomix
- Website
- https://nmgenomix.com
- Company type
- Private
- Headcount range
- 1–10 employees
- Short description
- NM Genomix is a small, privately held, for-profit healthcare organization headquartered in Sofia, Bulgaria, operating with 1–10 employees to provide medical services and products. Its specific clinical focus, customer base, and product portfolio are not disclosed in available sources.
- Ownership category
- akta.pro rank
NM Genomix industry classification
Industry- Product category
- Genomic Testing Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Genetic & Prenatal Testing Laboratories (HLAFAMAH)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where NM Genomix is headquartered
LocationHeadquarters
- HQ city
- Sofia
- HQ country
- Bulgaria
- HQ region
- Europe
Markets served
NM Genomix business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
NM Genomix product offering
Product offeringCore offering
NM Genomix is a Bulgaria-based healthcare organization that provides medical services and products, likely related to genomic and genetic testing given the "Genomix" branding. Specific product/service details could not be verified from the source data, as the company website was inaccessible beyond a bot-verification page.
Differentiator
Problem solved
Functional benefit
Companies that use NM Genomix
Customer profileIdeal customer profiles1 record
NM Genomix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
NM Genomix competitors and assessment
Company assessmentDirect peers
- MyHeritage: Israel-based genetic testing and genealogy company with a consumer health-genetics offering. Comparable in delivering genetic insights to end users and operating an in-house lab pipeline.
- 23andMe: Consumer-facing genetic testing company providing health, ancestry, and trait reports. Comparable in the genetic testing delivery model, though oriented to direct-to-consumer rather than clinical channels.
- SOPHiA GENETICS: Swiss health-tech company offering AI-driven genomic analysis for clinical labs and hospitals. Comparable as a European-headquartered clinical genomics platform serving routine and complex testing.
- Invitae: US-based medical genetics company offering a broad menu of clinical genetic tests. Comparable as a multi-indication clinical genetic testing service with similar customer segments (clinicians, hospitals, patients).
- Centogene: Rostock-based clinical genomics company focused on rare disease and genetic diagnostics across Europe. Closest comparable in scale and clinical-genomics focus for a small EU genetic testing lab.
- Natera: US-based clinical genetic testing company specializing in reproductive health, oncology, and organ transplant. Comparable for testing menu design and clinical evidence-driven go-to-market.
- Dante Labs: Italy-based genomics company offering whole-genome sequencing and genetic testing direct-to-consumer and via clinicians. Comparable as a European-headquartered genetic testing provider serving similar test categories.
- GeneDx: Clinical genomics company focused on rare disease and pediatric genetic testing. Comparable in clinical genetic testing workflow and rare-disease positioning.
Broad incumbents
- Eurofins Genomics: Division of Eurofins Scientific providing high-throughput genomic services globally. Comparable as a scaled, broad-line genetic testing service provider across the same customer base.
Emerging players
- Helix: US-based population genomics and clinical genetic testing company. Comparable as a newer-generation clinical genomics operator building a lab-plus-software model.
Market position
Strengths3 records
Weaknesses4 records
Key risks6 records
Key highlights3 records
Customer concentration
NM Genomix social profiles
Digital presenceNM Genomix financial estimates
Financial estimateRevenue estimate
Valuation estimate
NM Genomix leadership team
Management profileNumber of profiles
NM Genomix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NM Genomix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NM Genomix
What does NM Genomix do?
NM Genomix is a Bulgaria-based healthcare organization that provides medical services and products, likely related to genomic and genetic testing given the "Genomix" branding. Specific product/service details could not be verified from the source data, as the company website was inaccessible beyond a bot-verification page.
When was NM Genomix founded?
NM Genomix was founded in -1. It employs 1 to 10 people.
Where is NM Genomix based?
NM Genomix is headquartered in Sofia, Bulgaria, in the Europe region.
Who are NM Genomix's main competitors?
Direct peers on record are MyHeritage, 23andMe, SOPHiA GENETICS, Invitae, Centogene, Natera, Dante Labs and GeneDx. Eurofins Genomics is listed as a broad incumbent. Helix is listed as an emerging player.
Does NM Genomix have an API?
No public API is recorded for NM Genomix.
What industry is NM Genomix in?
NM Genomix's product category is Genomic Testing Services. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8734.